Peptide Vaccination with PR1 Elicits Active T Cell Immunity That Induces Cytogenetic Remission in Acute Myelogenous Leukemia.

Reviewer: Walter Sall, MD
OncoLink
Ultima Vez Modificado: 8 de diciembre del 2002

Translation for this article does not exist

Frequently Asked Questions